HK1009154A1 - Neural transplantation using pluripotent neuroepithelial cells - Google Patents
Neural transplantation using pluripotent neuroepithelial cellsInfo
- Publication number
- HK1009154A1 HK1009154A1 HK98110007A HK98110007A HK1009154A1 HK 1009154 A1 HK1009154 A1 HK 1009154A1 HK 98110007 A HK98110007 A HK 98110007A HK 98110007 A HK98110007 A HK 98110007A HK 1009154 A1 HK1009154 A1 HK 1009154A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- neuroepithelial cells
- pluripotent neuroepithelial
- neural transplantation
- cells
- pluripotent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518606.0A GB9518606D0 (en) | 1995-09-12 | 1995-09-12 | Neural transplantation |
PCT/GB1996/002251 WO1997010329A1 (en) | 1995-09-12 | 1996-09-12 | Neural transplantation using pluripotent neuroepithelial cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1009154A1 true HK1009154A1 (en) | 1999-05-28 |
Family
ID=10780583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98110007A HK1009154A1 (en) | 1995-09-12 | 1998-08-19 | Neural transplantation using pluripotent neuroepithelial cells |
Country Status (21)
Country | Link |
---|---|
US (3) | US7048921B2 (hu) |
EP (1) | EP0850298B1 (hu) |
JP (1) | JP4280872B2 (hu) |
KR (1) | KR19990044606A (hu) |
CN (1) | CN1193345A (hu) |
AT (1) | ATE242316T1 (hu) |
AU (1) | AU711563B2 (hu) |
CA (1) | CA2231436C (hu) |
CZ (1) | CZ296669B6 (hu) |
DE (1) | DE69628566T2 (hu) |
DK (1) | DK0850298T3 (hu) |
ES (1) | ES2196172T3 (hu) |
GB (1) | GB9518606D0 (hu) |
HK (1) | HK1009154A1 (hu) |
HU (1) | HUP9802091A3 (hu) |
NO (1) | NO981072L (hu) |
PL (1) | PL186777B1 (hu) |
PT (1) | PT850298E (hu) |
RU (1) | RU2185833C2 (hu) |
SK (1) | SK285816B6 (hu) |
WO (1) | WO1997010329A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222040B1 (hu) | 1994-11-08 | 2003-04-28 | Cellfactors Plc | Eljárás humán porc, csont és neurális sejtvonalak előállítására |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
KR100801764B1 (ko) * | 1999-09-17 | 2008-02-05 | 레뉴런 리미티드 | 세포의 조건부 불멸화 |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
ES2294650T3 (es) | 2004-09-30 | 2008-04-01 | Reneuron Limited | Linea celular. |
HUE030872T2 (hu) * | 2007-05-29 | 2017-06-28 | Christopher B Reid | Eljárások multipotens sejtpopulációk, pluripotens sejtpopulációk, differenciált sejtpopulációk és HIV-rezisztens sejtpopulációk elõállítására és azok alkalmazásai |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
US20150232662A1 (en) * | 2014-02-20 | 2015-08-20 | Sabic Innovative Plastics Ip B.V. | Thermoplastic composition and article |
WO2015171928A2 (en) * | 2014-05-07 | 2015-11-12 | Joslin Diabetes Center, Inc. | Methods and compositions for induction of ucp1 expression |
CN116590345B (zh) * | 2023-05-06 | 2024-01-30 | 北京中医药大学 | 永生化小鼠足细胞系及其制备方法、分化方法和应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US28510A (en) * | 1860-05-29 | John e | ||
US146821A (en) * | 1874-01-27 | Improvement in nose-pieces of nail-plate feeders | ||
US203483A (en) * | 1878-05-07 | Improvement in honey-boxes | ||
US147873A (en) * | 1874-02-24 | Improvement in nasal yokes for animals | ||
US1662A (en) * | 1840-06-27 | ariel nobris | ||
US913443A (en) * | 1908-08-13 | 1909-02-23 | Webster Full Expansion Rotary Engine Company | Rotary engine. |
NZ226750A (en) * | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
WO1989009816A1 (en) | 1988-04-12 | 1989-10-19 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5270191A (en) | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5070191A (en) * | 1989-04-27 | 1991-12-03 | Ajinomoto Co., Inc. | Demethylallosamidin and a process for production thereof |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
WO1991009936A1 (en) * | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
RU2028089C1 (ru) * | 1990-10-16 | 1995-02-09 | Украинский научно-исследовательский институт нейрохирургии | Способ лечения апаллического синдрома |
AU665012B2 (en) * | 1991-07-08 | 1995-12-14 | Neurospheres Holdings Ltd | Novel growth factor-responsive progenitor cells which can be proliferated (in vitro) |
US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
CA2131368A1 (en) | 1992-03-04 | 1993-09-16 | Chu-Chih Shih | Culturing of hematopoietic stem cells and their genetic engineering |
ES2170096T3 (es) * | 1993-04-13 | 2002-08-01 | Us Gov Health & Human Serv | Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes. |
US5753491A (en) * | 1993-04-13 | 1998-05-19 | Us Health | Use of neuro-derived fetal cell lines for transplantation therapy |
HU222040B1 (hu) * | 1994-11-08 | 2003-04-28 | Cellfactors Plc | Eljárás humán porc, csont és neurális sejtvonalak előállítására |
WO1996015226A1 (en) * | 1994-11-14 | 1996-05-23 | Neurospheres Holdings Ltd. | Regulation of neural stem cell proliferation |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517263D0 (en) * | 1995-08-23 | 1995-10-25 | Cancer Res Campaign Tech | Expression systems |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5588692A (en) * | 1995-10-11 | 1996-12-31 | General Motors Corporation | Push-out vehicle side door |
IL128348A (en) | 1996-08-19 | 2008-08-07 | Univ Massachusetts | Method of producing embryonic or stem like cell lines by transplantation of cell nuclei from animal or mammal, such cells and uses thereof |
SE9604322D0 (sv) * | 1996-11-25 | 1996-11-25 | Astra Ab | Bacterial antigens and vaccine compositions II |
US20020123143A1 (en) | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
US5958767A (en) * | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) * | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) * | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
JP2004500824A (ja) * | 2000-03-09 | 2004-01-15 | クリオ−セル インターナショナル インコーポレーティッド | 脳および脊髄の修復のための神経組織源としてのヒト臍帯血 |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
AU2001264763A1 (en) | 2000-06-05 | 2001-12-17 | University Of South Florida | Human mesenchymal progenitor cell |
US7049072B2 (en) * | 2000-06-05 | 2006-05-23 | University Of South Florida | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
WO2003029432A2 (en) | 2001-10-03 | 2003-04-10 | University Of South Florida | Human mesenchymal progenitor cell |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
ES2294650T3 (es) * | 2004-09-30 | 2008-04-01 | Reneuron Limited | Linea celular. |
-
1995
- 1995-09-12 GB GBGB9518606.0A patent/GB9518606D0/en active Pending
-
1996
- 1996-09-12 WO PCT/GB1996/002251 patent/WO1997010329A1/en active IP Right Grant
- 1996-09-12 KR KR1019980701856A patent/KR19990044606A/ko not_active Application Discontinuation
- 1996-09-12 DE DE69628566T patent/DE69628566T2/de not_active Expired - Lifetime
- 1996-09-12 PL PL96325646A patent/PL186777B1/pl unknown
- 1996-09-12 PT PT96930260T patent/PT850298E/pt unknown
- 1996-09-12 HU HU9802091A patent/HUP9802091A3/hu unknown
- 1996-09-12 AT AT96930260T patent/ATE242316T1/de not_active IP Right Cessation
- 1996-09-12 CA CA002231436A patent/CA2231436C/en not_active Expired - Lifetime
- 1996-09-12 CN CN96196376A patent/CN1193345A/zh active Pending
- 1996-09-12 EP EP96930260A patent/EP0850298B1/en not_active Expired - Lifetime
- 1996-09-12 SK SK306-98A patent/SK285816B6/sk unknown
- 1996-09-12 CZ CZ0055898A patent/CZ296669B6/cs not_active IP Right Cessation
- 1996-09-12 DK DK96930260T patent/DK0850298T3/da active
- 1996-09-12 AU AU69375/96A patent/AU711563B2/en not_active Expired
- 1996-09-12 ES ES96930260T patent/ES2196172T3/es not_active Expired - Lifetime
- 1996-09-12 JP JP51175697A patent/JP4280872B2/ja not_active Expired - Lifetime
- 1996-09-12 RU RU98107327/14A patent/RU2185833C2/ru not_active IP Right Cessation
-
1998
- 1998-03-11 NO NO981072A patent/NO981072L/no not_active Application Discontinuation
- 1998-08-19 HK HK98110007A patent/HK1009154A1/xx not_active IP Right Cessation
-
2001
- 2001-01-12 US US09/760,274 patent/US7048921B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/376,119 patent/US20030147873A1/en not_active Abandoned
-
2005
- 2005-07-08 US US11/178,216 patent/US7371374B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2231436A1 (en) | 1997-03-20 |
DE69628566D1 (de) | 2003-07-10 |
US20030147873A1 (en) | 2003-08-07 |
JP4280872B2 (ja) | 2009-06-17 |
US20060051326A1 (en) | 2006-03-09 |
JPH11513242A (ja) | 1999-11-16 |
CA2231436C (en) | 2007-07-17 |
PL325646A1 (en) | 1998-08-03 |
CZ296669B6 (cs) | 2006-05-17 |
DK0850298T3 (da) | 2003-09-15 |
GB9518606D0 (en) | 1995-11-15 |
SK30698A3 (en) | 1999-01-11 |
NO981072L (no) | 1998-05-12 |
HUP9802091A3 (en) | 2001-01-29 |
AU711563B2 (en) | 1999-10-14 |
AU6937596A (en) | 1997-04-01 |
US20010001662A1 (en) | 2001-05-24 |
RU2185833C2 (ru) | 2002-07-27 |
US7048921B2 (en) | 2006-05-23 |
PT850298E (pt) | 2003-09-30 |
HUP9802091A2 (hu) | 1998-12-28 |
US7371374B2 (en) | 2008-05-13 |
CZ55898A3 (cs) | 1998-06-17 |
DE69628566T2 (de) | 2004-05-06 |
ATE242316T1 (de) | 2003-06-15 |
KR19990044606A (ko) | 1999-06-25 |
CN1193345A (zh) | 1998-09-16 |
EP0850298A1 (en) | 1998-07-01 |
SK285816B6 (sk) | 2007-09-06 |
PL186777B1 (pl) | 2004-02-27 |
NO981072D0 (no) | 1998-03-11 |
EP0850298B1 (en) | 2003-06-04 |
ES2196172T3 (es) | 2003-12-16 |
WO1997010329A1 (en) | 1997-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1009154A1 (en) | Neural transplantation using pluripotent neuroepithelial cells | |
WO2001036589A3 (en) | Human ex vivo immune system | |
WO1997012960A3 (en) | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system | |
DE69609222D1 (de) | Partikel auf Polyaminosäure(n)basis zur Verwendung als Wirkstoffträger sowie deren Herstellungsverfahren | |
IL143283A0 (en) | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells | |
BG104095A (en) | Male tissue preferable regulatory section and method for its application | |
IL121790A0 (en) | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product | |
MX340738B (es) | Terapia para deficiencia de a-galactosidasa a. | |
GB9308271D0 (en) | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method | |
WO1997015655A3 (de) | Neue künstliche gewebe, verfahren zu ihrer herstellung und ihre verwendung | |
HUT64595A (en) | Method for producing mammalian cytokine, il-11 | |
WO1997004097A3 (en) | Human CTLA-8 and uses of CTLA-8-related proteins | |
MY113045A (en) | Waste treatment plant and process | |
GR3005297T3 (hu) | ||
ES8403157A1 (es) | Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral. | |
DE69637709D1 (de) | Durch elektroporation vermittelter molekulartransfer in intakten pflanzen | |
WO1999029279A3 (en) | Long-term survival and regeneration of central nervous system neurons | |
ATE290385T1 (de) | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten | |
IL90414A (en) | Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals | |
AU5391886A (en) | Method and device for the in vitro culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants | |
PL310950A1 (en) | Novel imidazole quinoxalinones, method of obtaining them and their application | |
AU7577091A (en) | Process for the artificial stimulation of cells and cyte culture device | |
HU9600432D0 (en) | Novel tripeptides useful in immune and cns therapy | |
WO2003040304A3 (en) | Method of proliferation in neurogenic regions | |
EP0142109A3 (en) | Macromolecules extracted from cultured mesenchymal cells for the treatment of degenerative diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20160911 |